- D02.3 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM D02.3 became effective on October 1, 2022.
- This is the American ICD-10-CM version of D02.3 – other international versions of ICD-10 D02.3 may differ.
ICD-10-CM D02.3 is grouped within Diagnostic Related Group(s):
- 180 Respiratory neoplasms with mcc
- 181 Respiratory neoplasms with cc
- 182 Respiratory neoplasms without cc/mcc
Applicable To
- Carcinoma in situ of accessory sinuses
- Carcinoma in situ of middle ear
- Carcinoma in situ of nasal cavities
Type 1 Excludes
- carcinoma in situ of ear (external) (skin) (D04.2-)
- carcinoma in situ of nose NOS (D09.8)
- carcinoma in situ of skin of nose (D04.3)
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to D02.3: